Prime Medicine (PRME) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist

2.650
-0.250-8.62%

Close Feb 25 16:00 ET

2.650
0.0000.00%

Pre 04:47 ET

347.58MMarket Cap-1.29P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
Prime MedicineFeb 24 00:00 ET
BMO Capital Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $19
Moomoo NewsJan 15 07:33 ET · Ratings
Prime Medicine's Promising Prospects and Potential Catalysts Justify Buy Rating
TipRanksJan 15 07:25 ET · Ratings
Prime Drink Group Brief: Appointed Audrey Bouchard as Chief Financial Officer, Effective Immediately
MT NewswiresJan 14 10:09 ET
Prime Medicine Advances Gene Editing and Trials
TipRanksJan 13 08:35 ET
Gene Editing Stocks Drop as Intellia Announces Layoffs
Seeking AlphaJan 10 13:29 ET

Comments

Trytosaveabit

Nov 22, 2024 19:02

New 13D/A

$Prime Medicine (PRME.US)$ Prime Medicine | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund X, L.P.(11.8%),ARCH Venture Fund X Overage, L.P.(11.8%), etc.
SEC· 17:36

This_Guy

Nov 11, 2024 09:59

$Prime Medicine (PRME.US)$ 👀

Jaguar8

Oct 24, 2024 07:02

NEWS

$Prime Medicine (PRME.US)$
Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress